Cite
APA Citation
Sprague, S. M., & Ketteler, M. (2021). a safety evaluation of sucroferric oxyhydroxide for the treatment of hyperphosphatemia. Expert opinion on drug safety, 20(12), 1463–1472. http://access.bl.uk/ark:/81055/vdc_100146092630.0x00002e